Protocol for nationwide surveillance of Acute Encephalitis Syndrome (AES) in a network of tertiary care hospitals in India.

IF 3.4 3区 医学 Q2 INFECTIOUS DISEASES
Anoop Velayudhan, Harmanmeet Kaur, Rahul Dhodapkar, Labanya Mukhopadhyay, Rizwan S Abdulkader, Sabarinathan R, Valsan Philip Verghese, Lalit Dar, Rakesh Lodha, Ravi V, Sam Joy, Pragya Yadav, Amita Jain, Ajanta Sharma, Kaveri K, Sayantan Banerjee, Anitha Pm, Manjusree S, Bharti Malhotra, Baijayantimala Mishra, Mala Chhabra, Asim Sarfraz, Bashir Fomda, Mahima Mittal, Manoj Murhekar, Nivedita Gupta
{"title":"Protocol for nationwide surveillance of Acute Encephalitis Syndrome (AES) in a network of tertiary care hospitals in India.","authors":"Anoop Velayudhan, Harmanmeet Kaur, Rahul Dhodapkar, Labanya Mukhopadhyay, Rizwan S Abdulkader, Sabarinathan R, Valsan Philip Verghese, Lalit Dar, Rakesh Lodha, Ravi V, Sam Joy, Pragya Yadav, Amita Jain, Ajanta Sharma, Kaveri K, Sayantan Banerjee, Anitha Pm, Manjusree S, Bharti Malhotra, Baijayantimala Mishra, Mala Chhabra, Asim Sarfraz, Bashir Fomda, Mahima Mittal, Manoj Murhekar, Nivedita Gupta","doi":"10.1186/s12879-025-10963-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Advances in laboratory diagnostics have greatly enhanced the understanding of the infectious aetiologies of Acute Encephalitis Syndrome (AES) globally. However, these diagnostic tests are not widely utilized in many public-sector clinical settings in India. Significant gaps thus remain in the knowledge and understanding of the burden, etiological spectrum, and risk factors associated with AES occurring in India.</p><p><strong>Methods: </strong>The current manuscript outlines a protocol designed to characterize the infectious causes of AES in affected regions of India through a network of 12 selected tertiary care hospitals and their associated Virus Research and Diagnostic Laboratories (VRDLs). A standardized tiered testing algorithm accounting for a wide range of possible etiological agents of infectious AES has been developed for use in the protocol, which aims to employ serological and molecular techniques to diagnose AES-causing priority pathogens. Pathogens of interest have been grouped in the testing algorithm into five levels (Levels 1-5) in decreasing order of priority based on their reported incidence. Clinical samples from each patient will be collected at presentation at respective sites, and relevant demographic and clinical data will be obtained from hospital records. Approximately 20% of samples which test negative for Level 1-4 pathogens will be subjected to Next-Generation Sequencing (NGS) to identify less well known/rare infectious causes of AES (Level 5 pathogens). De-identified clinical and laboratory data will be recorded into a web-based portal and managed by a designated nodal laboratory responsible for coordinating and overseeing the surveillance. The protocol ensures quality laboratory testing through an External Quality and Assessment Programme (EQAP).</p><p><strong>Discussion: </strong>Results from this nationwide surveillance will yield crucial data to identify the causes of Acute Encephalitis Syndrome (AES) across India, supporting targeted public health interventions that could help reduce the disease burden. Additionally, this protocol serves as a model for a tiered laboratory algorithm for AES surveillance, providing a framework to guide similar initiatives in other regions.</p>","PeriodicalId":8981,"journal":{"name":"BMC Infectious Diseases","volume":"25 1","pages":"615"},"PeriodicalIF":3.4000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036155/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12879-025-10963-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Advances in laboratory diagnostics have greatly enhanced the understanding of the infectious aetiologies of Acute Encephalitis Syndrome (AES) globally. However, these diagnostic tests are not widely utilized in many public-sector clinical settings in India. Significant gaps thus remain in the knowledge and understanding of the burden, etiological spectrum, and risk factors associated with AES occurring in India.

Methods: The current manuscript outlines a protocol designed to characterize the infectious causes of AES in affected regions of India through a network of 12 selected tertiary care hospitals and their associated Virus Research and Diagnostic Laboratories (VRDLs). A standardized tiered testing algorithm accounting for a wide range of possible etiological agents of infectious AES has been developed for use in the protocol, which aims to employ serological and molecular techniques to diagnose AES-causing priority pathogens. Pathogens of interest have been grouped in the testing algorithm into five levels (Levels 1-5) in decreasing order of priority based on their reported incidence. Clinical samples from each patient will be collected at presentation at respective sites, and relevant demographic and clinical data will be obtained from hospital records. Approximately 20% of samples which test negative for Level 1-4 pathogens will be subjected to Next-Generation Sequencing (NGS) to identify less well known/rare infectious causes of AES (Level 5 pathogens). De-identified clinical and laboratory data will be recorded into a web-based portal and managed by a designated nodal laboratory responsible for coordinating and overseeing the surveillance. The protocol ensures quality laboratory testing through an External Quality and Assessment Programme (EQAP).

Discussion: Results from this nationwide surveillance will yield crucial data to identify the causes of Acute Encephalitis Syndrome (AES) across India, supporting targeted public health interventions that could help reduce the disease burden. Additionally, this protocol serves as a model for a tiered laboratory algorithm for AES surveillance, providing a framework to guide similar initiatives in other regions.

印度三级保健医院网络急性脑炎综合征(AES)全国监测方案。
背景:实验室诊断的进步极大地提高了全球对急性脑炎综合征(AES)感染病原学的认识。然而,在印度许多公共部门的临床环境中,这些诊断测试并没有得到广泛应用。因此,在认识和理解与印度发生的AES相关的负担、病因谱和危险因素方面仍存在重大差距。方法:目前的手稿概述了一项方案,旨在通过选定的12家三级医院及其相关的病毒研究和诊断实验室(vrdl)组成的网络,确定印度受影响地区AES的感染原因。已经开发了一种标准化的分层检测算法,用于考虑感染性AES的广泛可能病因,其目的是采用血清学和分子技术来诊断引起AES的优先病原体。感兴趣的病原体在测试算法中根据其报告的发病率按优先级递减顺序分为5个级别(1-5级)。每个病人的临床样本将在各自的地点进行介绍时收集,相关的人口统计和临床数据将从医院记录中获得。大约20%的1-4级病原体检测为阴性的样本将进行下一代测序(NGS),以确定不太为人所知/罕见的AES(5级病原体)感染原因。去识别的临床和实验室数据将被记录到一个基于网络的门户网站,并由负责协调和监督监测的指定节点实验室进行管理。该方案通过外部质量和评估计划(EQAP)确保实验室检测的质量。讨论:这一全国性监测的结果将提供关键数据,以确定印度各地急性脑炎综合征(AES)的病因,支持有针对性的公共卫生干预措施,有助于减轻疾病负担。此外,该协议可作为AES监测分层实验室算法的模型,为指导其他区域的类似行动提供框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Infectious Diseases
BMC Infectious Diseases 医学-传染病学
CiteScore
6.50
自引率
0.00%
发文量
860
审稿时长
3.3 months
期刊介绍: BMC Infectious Diseases is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious and sexually transmitted diseases in humans, as well as related molecular genetics, pathophysiology, and epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信